Trigyn : More than meets the eye - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Trigyn : More than meets the eye

Nov 15, 2000

Trigyn Technologies (formerly Leading Edge) had projected a 100% growth in turnover to US$ 40 m for FY01. Till the first half of FY01 the company has achieved a turnover of US$18 m. The company seems well on track to achieve its target. Trigyn has added 22 new clients in the last quarter, out of which 10 are for the product eVector. As a result, the contribution of products to the revenue has increased and body shopping (euphemistically know as employee augmentation) is down to around 22%. The business mix too has changed slightly in favour of Telecom. In short, Trigyn is moving up the value chain.

The company’s employee utilisation rate is around 85%. 60% of its employees are in to projects, 25% in product development, 7% are engaged in the training and the remaining 8% on the bench (waiting for assignments). This is comparable to its peers in the industry

The company’s revenues from Europe and Asia Pacific markets are improving, the positive results of which, will reflect in the coming quarter. Also, the company claims that its e-business clients are shifting from dot coms to corporate.

However, the above painted picture is very rosy. Let us look at the fine prints. For the second quarter there is a huge component of other income Rs 40 m in net profit (PAT). If you remove this component the company’s PAT has fallen (down 40%) compared to the previous quarter. The company explains that this other income is due to profits from forex fluctuations and the rest are earnings from interest. Last quarter this figure was just Rs 5 m.

Also, the operating profit margins for the company is 21%. This is way below the industry benchmark of above 30%. The company claims that this is because of the losses on account of E Capital solution (a company Trigyn has acquired). Trigyn is writing off around US$ 500,000 on account of non-payment from a client (which it refused to name). This is unheard of in the industry (except for Mastek).

Trigyn has made a tax provision at the rate of 33% this quarter. Considering all its businesses are from exports this tax provisioning seems strange. Trigyn’s sales recovery period is 105 days, which is higher than the industry average of 90 days.

(Rs m) 1QFY01 2QFY01 Change
Sales 201 238 18.5%
Other Income 5 40 775.2%
Expenditure 159 187 17.4%
Operating Profit (EBDIT) 42 52 22.8%
Operating Profit Margin (%) 20.9% 21.7%  
Interest 1 2 40.4%
Depreciation 6 7 15.9%
Profit before Tax 40 84 110.2%
Tax 5 27 480.9%
Profit after Tax/(Loss) 35 57 60.7%
Net profit margin (%) 17.5% 23.7%  
No. of Shares (eoy) (m) 14.8 14.8  
Diluted Earnings per share* 9.5 15.2  
P/E (at current price) 46 28  
*(annualised)      

To sum it up, increase in top line is easy as there is a severe dearth of solutions. But what matters the most and what will be critical to survival in the digital economy is the management.

But what baffles industry watchers is the company’s declining contribution from financial services products, especially at a time when this is the fastest growing segment in the software industry. This is surprising as Trigyn has a good amount of experience in the financial services industry. With hardly any solutions provider in the securities segment Trigyn can benefit from the first mover advantage. But currently this doesn’t seem to be happening.

Bottomline, caution is the buzzword, till the company comes out clean on all issues. Sustainability is not in grabbing opportunities but in delivering, profitably.


Equitymaster requests your view! Post a comment on "Trigyn : More than meets the eye". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

I Recommended this Stock over Page Industries because it's Relevant to Doubling Your Income (Profit Hunter)

Sep 7, 2020

Things are not often what they seem in the market and how you can take advantage of this.

The NASDAQ Whale Could Harm Your Portfolio (Fast Profits Daily)

Sep 7, 2020

The discovery of Softbank pushing up prices on the NASDAQ will cause volatility in the market. Stay alert!

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRIGYN TECHNOLOGIES SHARE PRICE


Sep 18, 2020 (Close)

TRACK TRIGYN TECHNOLOGIES

  • Track your investment in TRIGYN TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS